0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Prevention of Venous Thromboembolism after Knee Arthroplasty: A Randomized, Double-Blind Trial Comparing Enoxaparin with Warfarin

Jacques R. Leclerc, MD; William H. Geerts, MD; Louis Desjardins, MD; George H. Laflamme, MD; Bernard l'Esperance, MD; Christine Demers, MD; Jeannine Kassis, MD; Moira Cruickshank, MD, MSc; Lucinda Whitman, MD; and Fernand Delorme, MD
[+] Article and Author Information

From McGill University and Universite de Montreal, Montreal, Quebec, Canada; University of Toronto, Toronto, Ontario, Canada; Universite Laval, Ste. Foy, Quebec, Canada; and the University of Western Ontario, London, Ontario, Canada. Acknowledgments: The authors thank 1) Dr. Francois Jobin [Hopital du St-Sacrement], who contributed to the study design; 2) the surgeons who referred the patients: Drs. C.E. Brooks, E. Lenczner, D. Burke, and M. Tanzer (The Montreal General Hospital); Drs. J. Schatzker, M. Tile, and G. Hunter (Sunny-brook Health Science Centre); Drs. J.F. Fradet, P. Kinnard, F. Morin, R. Grenier, and R. Lirette (Centre Hospitalier de l'Universite Laval); Drs. G.H. Laflamme, P. Beaumont, and P. Ranger (Hopital du Sacre-Coeur); Drs. J.M. Levesque, G. Brochu, R. Cloutier, A. Normand, and J. Simard (Hopital du St-Sacrement); Drs. M. Fallaha and R. Antoun (Hopital Maisonneuve-Rosemont); Drs. R. Bourne and C. Rorabeck (University Hospital); and Drs. P. Rockwood, C. Lendells, N. Turner, F. Noftall, D. Squire, and D. Peddle [Memorial]; 3) the unblinded oral medication monitors: Dr. I. Webb (The Montreal General Hospital); Dr. R. Jay (Sunnybrook Health Science Center); Drs. M. Ruel, L. Couture, and J. Villeneuve (Centre Hospitalier de l'Universite Laval); Dr. M. Laurier (Hopital du Sacre-Coeur); Drs. C. Doyle and A. Blais (Hopital du St-Sacrement); Dr. R. Lavallee (Hopital Maisonneuve-Rosemont); Dr. R.K. Stuart (University Hospital); Drs. C. Richardson, G. Adams, and K. Grewal [Memorial]; 4) the research nurses: B. St-Jacques, S. Finkenbine, and L. Porco (The Montreal General Hospital); K. Code (Sunnybrook Health Science Center); L. St-Pierre and J. Cote (Centre Hospitalier de l'Universite Laval); N. Tasse and S. Carrignan (Hopital du Sacre-Coeur); J. Poulin and L. Dube (Hopital du St-Sacrement); S. Bornais (Hopital Maisonneuve-Rosemont); M. Lewinski (University Hospital); C. Bishop [Memorial]; 5) the Steering Committee: Dr. A.G.G. Turpie [chair] and Drs. S. Yusuf and J. Sadler; and 6) the Safety Committee: Dr. L. Joseph (chair) and Drs. M. David, G.P. Blake, and G. Paiement. Grant Support: By a research grant from Rhone-Poulenc Rorer Canada. Requests for Reprints: Jacques R. Leclerc, MD, Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285. Current Author Addresses: Dr. Leclerc: Cardiovascular Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1996;124(7):619-626. doi:10.7326/0003-4819-124-7-199604010-00001
Text Size: A A A

Objective: To compare the effectiveness and safety of fixed-dose enoxaparin and adjusted-dose warfarin in preventing venous thromboembolism after knee arthroplasty.

Design: A randomized, double-blind controlled trial.

Setting: 8 university hospitals.

Patients: 670 consecutive patients who had knee arthroplasty.

Intervention: Patients were randomly assigned to receive enoxaparin (30 mg subcutaneously every 12 hours) or adjusted-dose warfarin (international normalized ratio, 2.0 to 3.0). Both regimens were started after surgery.

Measurements: The primary end point was the incidence of deep venous thrombosis in patients with adequate bilateral venograms; the secondary end point was hemorrhage.

Results: Among the 417 patients with adequate venograms, 109 of 211 warfarin recipients (51.7%) had deep venous thrombosis compared with 76 of 206 enoxaparin recipients (36.9%) (P = 0.003). The absolute risk difference was 14.8% in favor of enoxaparin (95% CI, 5.3% to 24.1%). Twenty-two warfarin recipients (10.4%) and 24 enoxaparin recipients (11.7%) had proximal venous thrombosis (P > 0.2). The absolute risk difference was 1.2% in favor of warfarin (CI, −7.2% to 4.8%). The incidence of major bleeding was 1.8% (6 of 334 patients) in the warfarin group and 2.1% (7 of 336 patients) in the enoxaparin group (P > 0.2). The absolute risk difference was 0.3% in favor of warfarin (CI, −2.4% to 1.8%).

Conclusions: A postoperative, fixed-dose enoxaparin regimen is more effective than adjusted-dose warfarin in preventing total deep venous thrombosis after knee arthroplasty. No differences were seen in the incidence of proximal venous thrombosis or clinically overt hemorrhage.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)